ARDS Drug Development Summit

Kongressthemen
The coronavirus pandemic has catapulted ARDS into the limelight and offered a once in a lifetime opportunity to meaningfully study large patient populations with homogenous disease – revolutionizing the notoriously challenging drug development landscape and widening the window of therapeutic opportunity to treat ARDS for the first time ever.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/745323-3?pid=4832

Speakers: Eric Jenkins, Senior Medical Director, Athersys, Melanie Kelly, Chief Scientific Officer, Tetra Biopharma and more

https://go.evvnt.com/745323-0?pid=4832

Frau Kaltrina Kastrati